ViewRay (VRAY) Stock Forecast, Price & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ViewRay in the last twelve months. There are currently 6 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" VRAY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VRAY, but not buy additional shares or sell existing shares.
View VRAY analyst ratings or view top-rated stocks.

7 brokers have issued twelve-month price objectives for ViewRay's stock. Their VRAY share price forecasts range from $1.00 to $8.00. On average, they predict the company's stock price to reach $3.18 in the next year. This suggests a possible upside of 500.0% from the stock's current price.
View analysts price targets for VRAY or view top-rated stocks among Wall Street analysts.

ViewRay's stock was trading at $4.48 on January 1st, 2023. Since then, VRAY stock has decreased by 88.2% and is now trading at $0.5298.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023.
View our VRAY earnings forecast.

ViewRay, Inc. (NASDAQ:VRAY) released its quarterly earnings data on Wednesday, May, 10th. The company reported ($0.16) EPS for the quarter, missing analysts' consensus estimates of ($0.15) by $0.01. The business had revenue of $22.53 million for the quarter, compared to analyst estimates of $22.64 million. ViewRay had a negative trailing twelve-month return on equity of 120.48% and a negative net margin of 104.30%.

ETFs with the largest weight of ViewRay (NASDAQ:VRAY) stock in their portfolio include Invesco Nasdaq Future Gen 200 ETF (QQQS), SPDR S&P Health Care Equipment ETF (XHE), Principal Healthcare Innovators ETF (BTEC), iShares U.S. Medical Devices ETF (IHI),

ViewRay issued an update on its FY 2023 earnings guidance on Tuesday, April, 18th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $102.21 million-$117.54 million, compared to the consensus revenue estimate of $136.37 million.

5 employees have rated ViewRay Chief Executive Officer Scott Drake on Glassdoor.com. Scott Drake has an approval rating of 59% among the company's employees. This puts Scott Drake in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other ViewRay investors own include Alibaba Group (BABA), Amarin (AMRN), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Verastem (VSTM), Corbus Pharmaceuticals (CRBP), Viking Therapeutics (VKTX), AbbVie (ABBV), Accuray (ARAY) and Selecta Biosciences (SELB).

(VRAY) raised $52 million in an IPO on the week of April 6th 2015. The company issued 4,000,000 shares at $12.00-$14.00 per share. Cowen and Company and Stifel served as the underwriters for the IPO and BTIG and Brean Capital were co-managers.

ViewRay trades on the NASDAQ under the ticker symbol "VRAY."

ViewRay's stock is owned by many different retail and institutional investors. Top institutional shareholders include Artisan Partners Limited Partnership (8.44%), Fosun International Ltd (6.60%), BlackRock Inc. (5.81%), Neuberger Berman Group LLC (5.63%), FMR LLC (2.90%) and Group One Trading L.P. (0.00%). Insiders that own company stock include Brian K Roberts, Caley Castelein, Influence Ltd Strong, International Ltd Fosun, James F Dempsey, Scott William Drake, Susan C Schnabel and Zachary William Stassen.
View institutional ownership trends.

Shares of VRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of VRAY stock can currently be purchased for approximately $0.53.

ViewRay (NASDAQ:VRAY) has a market capitalization of $97.17 million and generates $102.21 million in revenue each year. The company earns $-107,330,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis.

The company employs 267 workers across the globe.

ViewRay's mailing address is 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146. The official website for the company is www.viewray.com. The company can be reached via phone at (440) 703-3210, via email at investors@viewray.com, or via fax at 800-417-3459.